Hi,I am Dr. Amitkumar Sharma (Internal Medicine Specialist). I will be looking into your question and guiding you through the process. Please write your question below.
Hello , My father is suffering from CIDP for t he Last 8 months and Hospitalized in the month of March ..We have given an IVIG and Plasma Exchange Treatement to him but there is no imrovement .. he is still on Ventillator support . My question : is there any other cure for this disases
Treatment with glucocorticoids is another option (60–80 mg prednisone PO daily for 1–2 months, followed by a gradual dose reduction of 10 mg per month as tolerated), but long-term adverse effects including bone demineralization, gastrointestinal bleeding, and cushingoid changes are problematic.
Patients of CIDP who fail therapy with IVIg, PE, and glucocorticoids may benefit from treatment with immunosuppressive agents such as azathioprine, methotrexate, cyclosporine, and cyclophosphamide, either alone or as adjunctive therapy.
CIDP associated with anti-CNTN1 and NF155 antibodies is typically refractory to IVIg, but a few studies suggest a response to rituximab, a monoclonal antibody.
Hope I have answered your queries. Let me know if I can assist you further.
Take care
Regards,
Dr. Tushar Kanti Biswas
I find this answer helpful
You found this answer helpful
Note: For more detailed guidance, please consult an Internal Medicine Specialist, with your latest reports. Click here..
Disclaimer: These answers are for your information only and not intended to replace your relationship with your treating physician.
This is a short, free answer.
For a more detailed, immediate answer, try our premium service
[Sample answer]
We use cookies in order to offer you most relevant experience and using this website you acknowledge that you have already read and understood our
Privacy Policy
Is Plasma Exchange Treatment Sufficient For CIDP?
Hello, Treatment with glucocorticoids is another option (60–80 mg prednisone PO daily for 1–2 months, followed by a gradual dose reduction of 10 mg per month as tolerated), but long-term adverse effects including bone demineralization, gastrointestinal bleeding, and cushingoid changes are problematic. Patients of CIDP who fail therapy with IVIg, PE, and glucocorticoids may benefit from treatment with immunosuppressive agents such as azathioprine, methotrexate, cyclosporine, and cyclophosphamide, either alone or as adjunctive therapy. CIDP associated with anti-CNTN1 and NF155 antibodies is typically refractory to IVIg, but a few studies suggest a response to rituximab, a monoclonal antibody. Hope I have answered your queries. Let me know if I can assist you further. Take care Regards, Dr. Tushar Kanti Biswas